PFM Health Sciences’s Celcuity CELC Stock Holding History

PFM Health Sciences’s Portfolio CELC Stock Details CELC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-53,349	Closed	-$539K	–	63
2025 Q1	$539K	Sell	53,349 -105,397	-66%	-$1.19M	0.04%	63
2024 Q4	$2.08M	Sell	158,746 -551,509	-78%	-$7.78M	0.16%	73
2024 Q3	$10.6M	Sell	710,255 -126,747	-15%	-$2.09M	0.61%	38
2024 Q2	$13.7M	Buy	837,002 +340,000	+68%	+$5.69M	0.75%	42
2024 Q1	$10.7M	Buy	497,002 +340,005	+217%	+$5.43M	0.53%	54
2023 Q4	$2.29M	Sell	156,997 -53,554	-25%	-$647K	0.14%	61
2023 Q3	$1.92M	Sell	210,551 -47,162	-18%	-$464K	0.09%	68
2023 Q2	$2.83M	Sell	257,713 -53,252	-17%	-$553K	0.11%	75
2023 Q1	$3.19M	Sell	310,965 -401,146	-56%	-$4.4M	0.15%	67
2022 Q4	$9.98M	Buy	712,111 +571,685	+407%	+$5.85M	0.42%	68
2022 Q3	$1.41M	Buy	+140,426	New	+$1.33M	0.05%	83

Other funds holding CELC

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return